lilly tirzepatide approval Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA in the cards? Eli Lilly strikes Zepbound deal

Available as both an injectable and oral medication, semaglutide mimics the GLP-1 hormone, reducing appetite and fostering sustainable weight loss

www.mayoclinic.org/.../syc-20378999 Mulu, W.,et al

Breakfast 1/2 cup raw oats cooked with 1 cup 1% low fat milk or unsweetened fortified soy milk and mixed with 1 tablespoon chia seeds 1 medium apple with skin Snack 6 whole grain crackers 1.5 ounces hard cheese, such as cheddar Lunch Turkey sandwich: 3 ounces reduced-sodium turkey deli meat, 2 slices whole wheat bread, 2 teaspoons mayonnaise 12 baby carrots 1 large orange Snack 3 cups air-popped popcorn Dinner 4 ounces cooked haddock or cod 1 cup three-bean salad 1/2 cup cooked brown rice or quinoa 1 cup blackberries or strawberries mixed with 3/4 cup plain fat-free Greek yogurt Do Fiber Supplements Have the Same Effects as Semaglutide

If your plan has one: Standard prior authorization for Wegovy will be denied Appeals are usually unsuccessful (exclusions are plan design decisions) Alternative coverage pathways may exist (cardiovascular or sleep apnea indications) If your plan excludes weight loss coverage, Wegovy has a cardiovascular indication and Zepbound has a sleep apnea indication

How GLP-1s Could Help the Heart These medications are primarily used to treat conditions, such as diabetes and obesity, both of which are cardiovascular risk factors